SV Dementia Discovery Fund (DDF)

SV Dementia Discovery Fund (DDF)

Venture Capital and Private Equity Principals

London, England 3,561 followers

About us

The SV Health Investor's Dementia Discovery Fund (DDF) is the world’s largest family of specialized venture capital funds that invests exclusively in companies developing or enabling novel therapeutics for dementia. Dementias including Alzheimer’s Disease are arguably the largest unmet medical need with over 55m patients worldwide. With more than $500m raised for this strategy, and offices in London and Boston, DDF capitalizes on global investment opportunities to fulfill its dual mandate of delivering measurable impact and generating significant financial returns. Utilizing its network of venture partners, entrepreneurs, leading scientists, and strategic partners, DDF invests in and creates new biotech companies and provides thought leadership in the field. DDF is enabled by its limited partners including major pharmaceutical companies (Biogen, Bristol Myers Squibb, Eli Lilly and Co., GSK, Johnson & Johnson, Otsuka (Astex), Pfizer and Takeda), along with AARP, Aegon, Bill Gates, British Patient Capital, NFL Players Association, Quest Diagnostics, UnitedHealth Group, and the non-profits Alzheimer’s Research UK and LifeArc. Learn more at www.ddf.vc.

Website
http://www.ddf.vc
Industry
Venture Capital and Private Equity Principals
Company size
51-200 employees
Headquarters
London, England
Type
Privately Held
Founded
2015
Specialties
Dementia and Venture Capital

Locations

Employees at SV Dementia Discovery Fund (DDF)

Updates

Similar pages

Browse jobs

Funding

SV Dementia Discovery Fund (DDF) 1 total round

Last Round

Grant

US$ 14.0M

See more info on crunchbase